Maxillary anterior ridge augmentation with recombinant human bone morphogenetic protein 2

Ryan K. Edmunds, Brian L. Mealey, Michael P. Mills, Daniel S. Thoma, John Schoolfield, David L. Cochran, Jim Mellonig

Producción científica: Articlerevisión exhaustiva

11 Citas (Scopus)

Resumen

No human studies exist on the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) on an absorbable collagen sponge (ACS) as a sole graft material for lateral ridge augmentation in large ridge defect sites. This series evaluates the treatment outcome of maxillary anterior lateral ridge augmentation with rhBMP-2/ACS. Twenty patients were treated with rhBMP-2/ACS and fixation screws for space maintenance. Cone beam volumetric tomography measurements were used to determine gain in ridge width, and a bone core biopsy was obtained. The mean horizontal ridge gain was 1.2 mm across sites, and every site gained width.

Idioma originalEnglish (US)
Páginas (desde-hasta)550-557
Número de páginas8
PublicaciónInternational Journal of Periodontics and Restorative Dentistry
Volumen34
N.º4
DOI
EstadoPublished - 2014

ASJC Scopus subject areas

  • Oral Surgery
  • Periodontics

Huella

Profundice en los temas de investigación de 'Maxillary anterior ridge augmentation with recombinant human bone morphogenetic protein 2'. En conjunto forman una huella única.

Citar esto